Injecting New Ideas into Managing Type 2 Diabetes

Evolving Roles of GLP-1 Receptor Agonists

Welcome to this T2DM CME Snapshot™ video series. Each 15-minute module offers focused education for endocrinologists and primary care providers with actionable recommendations on injectable noninsulin antihyperglycemic agents for T2DM. For a comprehensive curriculum that provides interactive discussions on recent evidence related to glucagon-like peptide-1 receptor agonists (GLP-1 RAs), clinician learners can complete all 4 modules and receive a full hour of AMA PRA Category 1 Credit™.

Jointly provided by the Elsevier Office of Continuing Medical Education, Dannemiller, and Integritas Communications.

 

This activity has been supported by independent educational grants from Novo Nordisk Inc.

Image SnapShot
Clinical Profiles of Current and Emerging GLP-1 RAs

Module 1 of 4

John E. Anderson, MD; Jack L. Leahy, MD
MODULE 1
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 08/08/2019

Image SnapShot
Reducing Cardiovascular Risk in Patients with T2DM

Module 2 of 4

John E. Anderson, MD; Jack L. Leahy, MD
MODULE 2
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 09/10/2019

Image SnapShot
Overcoming Barriers to Injectable Noninsulin Therapies

Module 3 of 4

John E. Anderson, MD; Jack L. Leahy, MD
MODULE 3
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 09/10/2019

Image SnapShot
Practical Recommendations for Noninsulin Injectable Therapies

Module 4 of 4

John E. Anderson, MD; Jack L. Leahy, MD
MODULE 4
Begin Activity

credit amount 0.25

credit type CME/CE

expiration 09/10/2019

Resource

Injecting New Ideas into Managing Type 2 Diabetes

Evolving Roles of GLP-1 Receptor Agonists